ArticleCancer discovery2019

Clonal Selection with RAS Pathway Activation Mediates Secondary Clinical Resistance to Selective FLT3 Inhibition in Acute Myeloid Leukemia.

Christine M McMahon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.